SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.510.0%10:15 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Proton who wrote (17777)3/21/1998 5:25:00 PM
From: Pseudo Biologist  Read Replies (1) of 32384
 
Peter, no, they did not provide the full data. I left the article at work, so I don't even have the partial data: one can assume most of the tombstones going to zero, but there are a few complicated cases for which it would be hard to trace back the actual return, such as the Hybritech takeover by Lilly.

The comparison you propose would indeed be quite interesting. It may be possible to do it for the last 5 or 10 years; probably not pretty for the biotechs. One caveat on the DRG vs BTK game is that the former is likely to remain quite stable (ignoring merger mania for the moment), while the latter is likely to have some future tombstones right now. So, your emphasis on current components , for the forward comparison, is important to note and take into account.

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext